This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verweij, P. E.
Right arrow Articles by Meis, J. F. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verweij, P. E.
Right arrow Articles by Meis, J. F. G. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 1999, p. 1186-1189, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Aspergillus Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management

Paul E. Verweij,1,* Kees Brinkman,2,dagger Herbert P. H. Kremer,3 Bart-Jan Kullberg,2 and Jacques F. G. M. Meis1

Departments of Medical Microbiology,1 Internal Medicine,2 and Neurology,3 University Hospital Nijmegen, Nijmegen, The Netherlands

Received 31 August 1998/Returned for modification 15 October 1998/Accepted 30 December 1998

The performance of antibody detection, antigen detection, and Aspergillus genus-specific PCR for diagnosing Aspergillus meningitis was investigated with 26 cerebrospinal fluid (CSF) samples obtained from a single patient with proven infection caused by Aspergillus fumigatus. Immunoglobulin G antibodies directed against Aspergillus were not detected by enzyme-linked immunosorbent assay in CSF or serum. The antigen galactomannan was detected in the CSF 45 days before a culture became positive, and Aspergillus DNA was detected 4 days prior to culture. Decline of the galactomannan antigen titer in the CSF during treatment with intravenous and intraventricular amphotericin B and intravenous voriconazole corresponded with the clinical response to treatment.


* Corresponding author. Mailing address: Department of Medical Microbiology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614356. Fax: 31-24-3540216. E-mail: p.verweij{at}mmb.azn.nl.

dagger Present address: Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.


Journal of Clinical Microbiology, April 1999, p. 1186-1189, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • van de Beek, D., Patel, R., Campeau, N. G., Badley, A., Parisi, J. E., Rabinstein, A. A., Manno, E. M., Wijdicks, E.F.M. (2008). Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients. Neurology 70: 2411-2413 [Full Text]  
  • Gunaratne, P. S., Wijeyaratne, C. N., Seneviratne, H. R. (2007). Aspergillus Meningitis in Sri Lanka -- A Post-Tsunami Effect?. NEJM 356: 754-756 [Full Text]  
  • Khan, Z. U., Ahmad, S., Mokaddas, E., Said, T., Nair, M. P., Halim, M. A., Nampoory, M. R., McGinnis, M. R. (2007). Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1->3)-{beta}-D-glucan in clinical specimens. J Med Microbiol 56: 129-132 [Abstract] [Full Text]  
  • Hummel, M., Spiess, B., Kentouche, K., Niggemann, S., Bohm, C., Reuter, S., Kiehl, M., Morz, H., Hehlmann, R., Buchheidt, D. (2006). Detection of Aspergillus DNA in Cerebrospinal Fluid from Patients with Cerebral Aspergillosis by a Nested PCR Assay. J. Clin. Microbiol. 44: 3989-3993 [Abstract] [Full Text]  
  • Clemons, K. V., Espiritu, M., Parmar, R., Stevens, D. A. (2005). Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis. Antimicrob. Agents Chemother. 49: 4867-4875 [Abstract] [Full Text]  
  • Singh, N., Paterson, D. L. (2005). Aspergillus Infections in Transplant Recipients. Clin. Microbiol. Rev. 18: 44-69 [Abstract] [Full Text]  
  • Verduyn Lunel, F. M., Voss, A., Kuijper, E. J., Gelinck, L. B. S., Hoogerbrugge, P. M., Liem, K. L., Kullberg, B. J., Verweij, P. E. (2004). Detection of the Candida Antigen Mannan in Cerebrospinal Fluid Specimens from Patients Suspected of Having Candida Meningitis. J. Clin. Microbiol. 42: 867-870 [Abstract] [Full Text]  
  • Nulens, E., Eggink, C., Rijs, A. J. M. M., Wesseling, P., Verweij, P. E. (2003). Keratitis Caused by Scedosporium apiospermum Successfully Treated with a Cornea Transplant and Voriconazole. J. Clin. Microbiol. 41: 2261-2264 [Abstract] [Full Text]  
  • Pearson, M. M, Rogers, P D., Cleary, J. D, Chapman, S. W (2003). Voriconazole: A New Triazole Antifungal Agent. The Annals of Pharmacotherapy 37: 420-432 [Abstract] [Full Text]  
  • Yeo, S. F., Wong, B. (2002). Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections. Clin. Microbiol. Rev. 15: 465-484 [Abstract] [Full Text]  
  • Viscoli, C., Machetti, M., Gazzola, P., De Maria, A., Paola, D., Van Lint, M. T., Gualandi, F., Truini, M., Bacigalupo, A. (2002). Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis. J. Clin. Microbiol. 40: 1496-1499 [Abstract] [Full Text]  
  • Posteraro, B., Sanguinetti, M., Masucci, L., Romano, L., Morace, G., Fadda, G. (2000). Reverse Cross Blot Hybridization Assay for Rapid Detection of PCR-Amplified DNA from Candida Species, Cryptococcus neoformans, and Saccharomyces cerevisiae in Clinical Samples. J. Clin. Microbiol. 38: 1609-1614 [Abstract] [Full Text]